Cargando…
Intravenous lidocaine infusion in a case of severe COVID-19 infection
A subset of patients with COVID-19 develops a severe inflammatory response that may lead to respiratory and multiorgan failure. Effective treatment strategies to mitigate or interrupt this self-destructive inflammatory process are limited. The local anesthetic lidocaine has anti-inflammatory propert...
Autores principales: | Rylova, Anna, Chowdhury, Seema, Amirfarzan, Houman, Leissner, Kay B., Schumann, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562453/ https://www.ncbi.nlm.nih.gov/pubmed/34759566 http://dx.doi.org/10.4103/joacp.JOACP_562_20 |
Ejemplares similares
-
Continuous intravenous lidocaine infusion for postoperative pain and recovery in adults
por: Paterson, Hugh M.
Publicado: (2019) -
Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic Pain
por: Tully, Janell, et al.
Publicado: (2021) -
Use of Helmet CPAP in COVID-19 – A practical review
por: Amirfarzan, H., et al.
Publicado: (2021) -
Helmet CPAP: how an unfamiliar respiratory tool is moving into treatment options during COVID-19 in the US
por: Armirfarzan, Houman, et al.
Publicado: (2020) -
Intravenous infusion of lidocaine enhances the efficacy of conventional treatment of postherpetic neuralgia
por: Tan, Xinran, et al.
Publicado: (2019)